GlucoSentient, Inc.
Diagnostics company · Champaign, Illinois, United States
GlucoSentient, Inc. is a diagnostics company headquartered in Champaign, Illinois, United States. Its earliest recorded incorporation is in 2011. It has received 9 US government small-business research awards (SBIR/STTR) from health agencies, $3.2 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $60,000 sold in a notice filed in 2012.
GlucoSentient at a glance
What does GlucoSentient do?
US government research funding
9 SBIR/STTR small-business research awards from US health agencies, $3.2 million in total (2013 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $60,000 sold (2012).
Frequently asked questions about GlucoSentient
Where is GlucoSentient headquartered?
GlucoSentient, Inc. is headquartered in Champaign, Illinois, United States.
What does GlucoSentient do?
GlucoSentient, Inc. is a diagnostics company.
When was GlucoSentient founded?
The earliest incorporation on record for GlucoSentient, Inc. is in 2011, according to public company registers.
Similar companies
- Prenosis, Inc.Champaign, Illinois, United States
- Photonicare IncChampaign, Illinois, United States
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Visby Medical, Inc.San Jose, California, United States
- Lucira Health, Inc.Emeryville, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences